Insulin- and Glucose Metabolism in Pulmonary Arterial Hypertension
NCT ID: NCT03584607
Last Updated: 2020-01-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
10 participants
OBSERVATIONAL
2017-12-20
2019-02-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
the No-reflow in Diabetic Patients Treated With Primary Percutaneous Coronary Intervention (PCI)
NCT04835974
Diabetes Mellitus - A Diagnosis Trial by Means of Non Invasive Measurements
NCT02028091
Mechanisms of Pro-Thrombosis in Diabetes Mellitus -- Ancillary to BARI 2D
NCT00041405
Metabolomic Profiling of Novel Mediators of Vascular Function
NCT00762242
Survey on the Treatment of Hypertension in Patients With Type 2 Diabetes
NCT00803660
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Idiopathic Pulmonary Arterial Hypertension patients
Blood sampling Insulin resistance-measurement
No interventions assigned to this group
Healthy controls
Blood sampling Insulin resistance-measurement
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients with idiopathic or hereditary pulmonary hypertension / healthy controls
Exclusion Criteria
* other relevant lung disease
* relevant left heart disease
* untreated systemic hypertension
* Diabetes mellitus
* pulmonary hypertension other than idiopathic or hereditary form
18 Years
90 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University of Graz
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bence M. Nagy, PhD
Role: PRINCIPAL_INVESTIGATOR
Medical University of Graz
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical University Graz, Division of Pulmonology
Graz, Styria, Austria
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Nagy BM, Kovacs G, Tornyos A, Svehlikova E, Foris V, Nagaraj C, Kwapiszewska G, Pieber TR, Olschewski A, Olschewski H. No indication of insulin resistance in idiopathic pulmonary arterial hypertension with preserved physical activity. Eur Respir J. 2020 Jun 11;55(6):1901228. doi: 10.1183/13993003.01228-2019. Print 2020 Jun. No abstract available.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
29-066 ex 16/17
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.